Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 651 results found. Search for [ coronavirus vaccine price ]

Results 80 to 100 of 651
PTI
April 22, 2021
Gorakhpur MLA Radha Mohan Das Agrawal made the remarks after SII on Wednesday announced a price of Rs 600 per dose for Covishield supplies to private hospitals and Rs 400 per dose to state governments


BusinessToday.In
April 22, 2021
In order to speed up the nationwide vaccination drive, the Centre had last week fast-tracked approval process for foreign vaccines which have been approved by the drug regulators in US, Europe, UK and Japan


BusinessToday.In
April 22, 2021
\"It is clarified that the CoWIN platform will be ready for 18+ beneficiaries by April 24, however, the registrations to book appointments (starting May 1) will begin only from April 28, 2021 (sic),\" MyGovIndia said in a tweet.


BusinessToday.In
April 21, 2021
\"Going ahead, 50% of our capacities will be served to the Government of India's vaccination program, and the remaining 50% of the capacity will be for the State governments and private hospitals,\" Adar Poonawalla stated


Joe C Mathew
April 21, 2021
Former Health Secretary K Sujatha Rao has been warning against the opening up of vaccine administration without proper planning to ensure adequate supplies and pricing mechanisms


Shailendra Shukla
New Delhi, April 21, 2021
PM Modi speech Highlights: 'Lockdown last resort; focus on micro-containment' Prime Minister Narendra Modi addressed the nation on Tuesday and spoke about the prevailing COVID-19 situation in the country. He said the situation in India was under control until some weeks ago, but the second wave of COVID has come like a storm. The prime minister said India is currently fighting a very tough battle against coronavirus and urged people to follow COVID-appropriate behaviour. Prime Minister Nare...


BusinessToday.In
April 21, 2021
Coronavirus in India: Vaccine manufacturers have also urged the government to price vaccine doses at rates that are globally competitive


BusinessToday.In
April 20, 2021
In a tweet, Gandhi said, \"After experiencing mild symptoms, I've just tested positive for COVID.\"


Manoj Sharma
April 20, 2021
If their previous statements are any indication, hiked prices of vaccines could be anywhere between Rs 1,000- Rs 2,000. Poonawalla had earlier said the vaccine could be sold at Rs 1,000 per dose to private players, while Bharat Biotech's Krishna Ella said prices were likely to go up initially


BusinessToday.In
April 20, 2021
Corona vaccine for above 18 years: Among Bollywood stars, the first ones to react to the news were Alia Bhatt and Katrina Kaif who had tested COVID-19 positive earlier this month


BusinessToday.In
April 20, 2021
Under the Phase 3 vaccination policy, vaccine makers will supply 50 per cent of their doses to the Centre and the remaining 50 per cent to states and in the open market


Ashutosh Kumar
April 19, 2021
The government will make pre-payment to both Serum Institute of India and Bharat Biotech for the vaccine supply. \"This will serve as an incentive to the two vaccine suppliers,\" said a source


BusinessToday.In
April 19, 2021
States have been empowered to procure additional vaccine doses directly from the manufacturers, as well as open up vaccination to any category of people above the age of 18 years.


Reuters
April 16, 2021
Facing soaring cases and overflowing hospitals after lockdown restrictions were eased, it also abruptly changed the rules to allow it to fast-track vaccine imports, having earlier rebuffed foreign drugmakers like Pfizer


Reuters
April 14, 2021
Most Asia-Pacific share indexes followed Wall Street higher, with Hong Kong's Hang Seng leading gains in the region, while benchmark US Treasury yields continued their decline, marking a fresh three-week low


Reuters
April 14, 2021
The vaccine maker said the six-month follow-up of its original late-stage study of the vaccine showed that vaccine efficacy remained consistent with its previous updates


Associated Press
April 14, 2021
The Johnson & Johnson pause, which regulators say they hope to resolve within days, comes on the heels of production issues at the Baltimore plant that produces the J&J vaccine


Reuters
April 14, 2021
The bloc is seeking the new supply deal with the two companies for up to 1.8 billion vaccines, of which is 900 million optional, to be delivered in 2022 and 2023


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


PAGES 5 OF 33  12345